Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $40.0000 (-2.44%) ($39.5000 - $40.0000) on Tue. Nov. 18, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.68% (three month average) | RSI | 63 | Latest Price | $40.0000(-2.44%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | CAPR advances 1.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) JNK(7%) VT(7%) XLF(7%) EWG(6%) EWI(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.34% in a week (0% probabilities). VIXM(-5%) TLT(-4%) SHY(-2%) GLD(-2%) UUP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.34% (StdDev 4.68%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $40.48(-1.19%) | 10 Day Moving Average | $40.25(-0.62%) | 20 Day Moving Average | $39.73(0.68%) | To recent high | -8.9% | To recent low | 14.3% | Market Cap | $788m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |